BRIEF OVERVIEW OF XEROSTOMIA PROBLEM
https://doi.org/10.17650/2222-1468-2015-1-42-44
Abstract
The saliva is indispensable for preservation of healthy mouth and teeth, due to its composition and physical and chemical properties. Saliva preserves the teeth and favors their remineralization for account of afflux of irreplaceable minerals: calcium and phosphor. Due to contents of such epidermal growth factor it participates in tissue repair. The saliva contains the antibacterial, antiviral and antifungal drug resistance factors, suppressing the bacterial colonization of teeth and mucosa.
Dry mouth (xerostomia) results in development of stomatitis, periodontitis effects, increases a risk of infectious lesions of oral mucosa. The severest forms of such pathology (Degrees II–III) are observed in the patients administered of X-ray therapy on head and neck area and in case of Sjogren’s syndrome, when the irreversible degenerative changes develop in эпителии salivary glands epithelium. Etiology and pathogenesis of xerostomia are not exhaustively studied yet, and treatment of such complex pathology is still symptomatic.
About the Author
S. O. Podvyaznikov
Russian Medical Postgraduate Academy, Moscow
Russian Federation
Russian Federation
Oncology Department of «RussianMedicalPostgraduateAcademy», Ministry of Health ofRussia; 2/1, Barrikadnaya Str., 125993,Russia,Moscow
References
1. Madinier I., Jehl-Pietri C., Monteil R.A. Les hyposialies d’origine medicamenteuse. Ann Med Interne 1997;148:398–405.
2. Sciubba J.J., Goldenberg D. Oral complications of radiotherapy. Lancet Oncol 2006;7(2):175–83.
3. Dodds M.W., Johnson D.A., Yeh C.K. Health benefits of saliva: a review. J Dent 2005;33:223–33.
4. Scully C. Drag effect on salivary glands: dry mouth. Oral Dis 2003;9:165–76.
5. Altkinson J.C., Grisius M., Massey W. Salivary hypofunction and xerostomia: diagnosis and treatment. Dent Clin North Am 2005;49(2): 309–26.
6. Gentric-Tilly A. Sjögren's syndrome in the elderly. Ann Med Interne (Paris) 2002;153:378–82.
7. Guggenheimer J., Moore P.A. Xerostomia: etiology, recognition and treatment. J Am Dent Assos 2003;13:61–9.
8. Mariette X. Treatment of oral dryness in Sjögren's syndrome. Rev Med Interne 2004;25:287–93.
9. Dirix P., Nuyts S., Van den Bogaert W. Radiation-induced xerostomia in patients with head and neck cancer: a literature review. Cancer 2006;107(1):2525–34.
10. Vissink A., Burlage F.R., Spijkervet F.K. et al. Prevention and treatment of salivary gland hypofunction related to head and neck radiation therapy and chemotherapy. Support Cancer Ther 2004;1:111–8.
11. Seikaly H., Jha N., Harris J.R. et al. Longterm outcomes of submandibular gland transfer for prevention of postradiation xerostomia. Arch Otolaringol Head Neck Surg 2004;130:956–61.
12. Novaresh M. et al. JADA 2008;139:355–405.
13. Thomson W.M., Chalmers J.M., Spencer A.J., Ketabi M. The occurrence of xerostomia and salivary gland hypofunction in a populationbased sample of older South Australians. Spec Care Dentist 1999;19(1):20–3.
14. Turner M., Jahangiri L., Ship J.A. Hyposalivation, xerostomia fnd the complete denture: a systematic review. J Am Dent Assoc 2008;139: 146–50.
Review
For citations:
Podvyaznikov S.O. BRIEF OVERVIEW OF XEROSTOMIA PROBLEM. Head and Neck Tumors (HNT). 2015;5(1):42-44. (In Russ.) https://doi.org/10.17650/2222-1468-2015-1-42-44
Views:
1218
Email this article 